← Leaderboards
Christopher Fox
Access To Advanced Health Institute
$8,540,962
Attributed
$8,540,962
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2019–24$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,540,962 · 1
By mechanism
N01$8,540,962 · 1
Top collaborators
No co-investigators on record.
Most similar at Access To Advanced Health Institute
Same institution · by research overlap
- Rhea N Coler$15,369,963
- Jesse Hong-Sae Erasmus$5,357,788
- Christopher B Fox$4,575,361
- Neal Van Hoeven$10,968,365
- Chris Fox$12,111,300
Others in their field
Other Emerging Leaders on “Vaccines”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$149,372,007
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Ted Ross · University Of Georgia$71,962,304
Research focus
VaccinesAdvanced DevelopmentContractsEfficacy TestingEntamoeba HistolyticaFormulationImmunogenicityResearch Clinical TestingStability TestingToxicologyNonhuman PrimateAdjuvantDoseManufactureAnimal ModelCommunicable DiseasesDisease OutbreaksEfficacy EvaluationResponseEmerging Communicable DiseasesSafetyVaccine Development
Grant awards (4)
Advanced Development and Clinical Evaluation of an Entamoeba Histolytica Vaccine$1,260,556
N01 · FY2024 · AI · contact PI
Advanced Development and Clinical Evaluation of an Entamoeba histolytica Vaccine$3,674,481
N01 · FY2022 · AI · contact PI
Advanced Development and Clinical Evaluation of an Entamoeba histolytica Vaccine$2,853,145
N01 · FY2021 · AI · contact PI
Advanced Development and Clinical Evaluation of an Entamoeba histolytica Vaccine$752,780
N01 · FY2019 · AI · contact PI